This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Review Articleiju_2963 416..428
Transumbilical laparoendoscopic single-site surgeryin urologyJohn E Humphrey and David CanesDepartment of Urology, Tufts University School of Medicine, Lahey Clinic Institute of Urology, Burlington, Massachusetts, USA
Abbreviations & AcronymsCL = conventionallaparoscopyDVT/PE = deep venousthrombosis/pulmonaryembolusEBL = estimated blood lossE-NOTES = embryonicnatural orificetransumbilical endoscopicsurgeryLap = laparoscopicLESS = laparoendoscopicsingle-site surgeryLOS = length of hospitalstayMAG3 = technetium-99mmercaptoacetyltriglycineMOT = mean operativetimeOPUS = one port umbilicalsurgerySIL = single incisionlaparoscopySILS = single portlaparoscopySPA = single port accessSPL = single portlaparoscopy
Correspondence: David CanesM.D., Department of Urology,Tufts University School ofMedicine, Lahey Clinic Instituteof Urology, 41 Mall Road ,Burlington, MA 01805, USA.Email: [email protected]
Received 18 October 2011;accepted 4 January 2012.Online publication 15 February2012
Abstract: Laparoendoscopic single-site surgery has seen a dramatic rise in the uro-logical community. With the advent of new techniques and instrumentation, laparoen-doscopic single-site surgery has become more accessible for a wide variety ofapplications. The majority have been carried out through a transumbilical incision inorder to effectively hide the scar within the umbilicus. Here, we review the history andclinical applications for transumbilical laparoendoscopic single-site surgery withinurology. The current scope is broad, and great strides have been made, but the overallbenefit appears to be predominantly cosmetic. Diffusion of laparoendoscopic single-sitesurgery techniques from tertiary referral centers to the community urologist remainsunknown. This review demonstrates the feasibility of transumbilical laparoendoscopicsingle-site surgery as shown in the urological literature.
Single-port surgery, like many advances in medicine, is the result of constant fine-tuning ofprior techniques, and questioning how they can be improved on. The initial impetus drivingtowards minimally invasive surgery was the morbidity from an open laparotomy incision.The pain, recovery time and inherent wound complications, such as infection and incisionalhernias, as well as the cosmetic nature of open surgery drove us to push the field towardslaparoscopic surgery, and subsequently its robotic counterpart. The subsequent evolution oftechnique, ability and technology has led to the development of transumbilical single-portsurgery. This is thought to be the next natural step in accomplishing safe, effective proce-dures while limiting the morbidity and cosmetic consequences of large and/or severalincisions.
Assumptions that surgical morbidity is simply linearly related to the sum-total of incisionlength(s), however, have not held under scrutiny in the past. The present review is focusedon the urological experience with single-port surgery specifically using a transumbilicalapproach. The umbilicus provides a location in which the resultant scar can be at leastpartially hidden from view, enhancing the benefit of improved cosmesis with single-portsurgery. The application of transumbilical single-port surgery in urology is ever growing,and herein we describe the worldwide use of this technique to date.
The term now used to describe single-port surgery in the urological literature is LESS.This was developed to incorporate and standardize the various previous terms used todescribe one overall concept of minimally invasive operations performed through a singleincision using conventional laparoscopic or newer instrumentation such as fixed pre-bent ordeflectable flexible instruments.1 Previous terms included E-NOTES, SILS, OPUS, SPA,SPL and SIL, among others. The first transumbilical urological LESS procedure describedwas by Raman et al. where three nephrectomies were carried out, each using a singleincision with multiple trocars.2 Since that time, the clinical experience has increased
bs_bs_banner
International Journal of Urology (2012) 19, 416–428 doi: 10.1111/j.1442-2042.2012.02963.x
dramatically and LESS has cemented itself as an excellenttechnique for a broad range of urological procedures.
Early history
The first description of a true LESS procedure, evident nowonly in retrospect, was in the field of gynecology for tuballigation in 1972.3 A 1-cm infraumbilical incision was made,through which a laparoscope was inserted to visualize andthen cauterize each fallopian tube. The fallopian tubes wereexposed using an external tenaculum placed on the uterusfrom the vagina. The cosmetic benefit of the technique wasimmediately evident, and eventually led gynecologists toexplore similar techniques for larger procedures, includingtotal abdominal hysterectomy and bilateral salpingo-oophorectomy by 1991.4
General surgeons also began to explore the use oftransumbilical LESS surgery for appendectomy andcholecystectomy.5–7 During this process, a new techniquewas developed in 1999 for use in cholecystectomy, by whicha single skin incision is made, but two fascial incisions areused to accommodate 5-mm trocars within this commonskin incision.8 This allows more ports for instrumentswithout compromising the cosmetic benefit.
Initial urological applications
Although LESS procedures were being developed in theseother arenas, the evolution from open to laparoscopic andfinally robotic surgery was taking place in urology. Thebenefits realized during this transition included less bleed-ing, fewer complications and shorter hospital stays leadingto faster convalescence.9 It was thus inevitable that urolo-gists would also begin exploring the single-port system.
Although we focus here on transumbilical LESS, in2007, the first case in urology used a flank incision forplacement of an R-port (Advanced Surgical Concepts,Wicklow, Ireland) to complete a nephrectomy on a small,non-functioning kidney.10 This technique has also beenused for radical nephrectomy with a 7-cm paramedian inci-sion just lateral to the rectus muscle for placement of aGelPort (Applied Medical, Rancho Santa Margarita, CA,USA).11 Another case report described a 4-cm flank inci-sion with a GelPort to carry out retroperitoneal radicalnephrectomy for renal cell carcinoma in a dialysis patient.12
The pfannenstiel incision has also been explored as a focalpoint for LESS. In one report, a 7.5-cm pfannenstiel inci-sion was used to carry out both nephrectomy and neph-roureterectomy, using a GelPort as an access device.13
These approaches proved to be feasible options utilizingnon-umbilical incisions. However, the majority of urologi-cal single-site experience, as described here, has been withtransumbilical access.
Benefits of LESS
The transition from CL to LESS creates inherent technicalchallenges. In order for the urological community at large toembrace LESS, clear benefits of LESS over CL must beshown rigorously and scientifically. This has been difficult,as the salient advantage is improved cosmesis, a variable forwhich there is a paucity of objective measures. An earlycomparison between LESS and CL among patients under-going nephrectomy showed a subjective cosmetic advan-tage, while also showing comparable outcomes for operativetime, analgesic use, hospital stay and complication rate.14
Similar subjective outcomes have been reproduced withvarious procedures,15–18 but a recent study by Park et al. usedan objective measure to quantify the cosmetic advantage.19
This group used a body image questionnaire to comparepatient satisfaction after kidney surgery. Although the scalewas non-validated, it does represent the first objectivemeasure of improved cosmesis with LESS. As rigorous datacontinues to accumulate, by preliminary observation itseems clear that at least from the surgeon’s perspective,cosmesis is excellent after umbilical LESS surgery. Figure 1shows the immediate intraoperative cosmetic result of apatient in our own group undergoing a LESS left renal cystdecortication. For this procedure, a 4-cm vertical intraum-bilical incision was made, with the result as shown at6 weeks postoperatively in Figure 2.
Other theoretical benefits of LESS include decreasedpostoperative pain and fewer postoperative wound compli-cations (infection, hernia). Jeong et al. presented dataamong patients undergoing adrenalectomy (9 LESS, 17 CL)showing significantly lower postoperative pain in the LESScohort.17 However, most comparison series have not hadlong enough follow up or were powered with sample sizesnecessary to show a meaningful difference in woundcomplications.
Fig. 1 LESS renal cyst decortication immediate cosmeticresult.
As with any new surgical platform, LESS has been associ-ated with unique ergonomic challenges to overcome andinherent difficulties, which continue to be present. Multiportlaparoscopic surgery with strategically placed trocarsachieves triangulation for improved tissue retraction andonly rare instrument clashing. Triangulation and instrumentcrowding becomes even more difficult during LESS,whereby bulky instrument handles clash in preciouslylimited external “real estate”. These difficulties have put theonus not only on the surgeon to creatively overcome theselimitations given current instruments, but also on industry todesign purpose-built access devices and instrumentation.The technical and equipment challenges with LESS havepreviously been described by Sawyer and Ponsky.20 Theynote the rapid innovation seen with LESS and highlight theobstacles that are inherent to single-port surgery. Twoapproaches are described: (i) a coaxial approach in whichinstruments are used in parallel; or (ii) a novel platform. Thecoaxial approach leads to limited visual perspective, asinstruments are in line with the operator’s vision. The tran-sition to novel platforms to overcome this challenge isdescribed below.
Before the current devices were created, surgeons firstexperimented by using existing laparoscopic instrumentsthrough a single skin incision and multiple fascial incisions.This “keyhole” technique (as described above as the firsturological transumbilical LESS procedure) was used tocomplete three nephrectomies (two for chronic infection,one for a 4.5-cm enhancing renal mass) with three adjacenttrocars in an umbilical incision.2 Articulating graspers, stan-dard endoshears and a 45° 5-mm rigid laparoscope or 5-mmdeflectable tip laparoscope were used. The authors citedinternal and external instrument collision as a constant chal-lenge, as well as a difficult learning curve. Similarly, adrena-
lectomy has been carried out using a 2-cm incision withadjacent trocars through multiple fascial punctures.21 Thefascial incisions were connected in these cases for specimenextraction. The three challenges noted were limited maneu-verability with tearing of port site fascia, difficult visualiza-tion and potential difficulty with vascular control. In order tomeet these challenges, new access platforms were createdthat depended on only one fascial incision with the potentialto accommodate up to three or four instruments at a time(such as with Triport and QuadPort; Advanced SurgicalConcepts). The main concept behind new platforms is toprovide access for multiple instruments through one incisionwhile limiting device profile. One solution is provided by theGelPOINT Advanced Access Platform (Applied Medical),which allows the surgeon to place multiple trocars throughany location in the device. Table 1 shows current accessdevices and instrumentation for LESS procedures. Figure 3shows an intraoperative view of the GelPOINT AdvancedAccess Platform being used for the aforementioned LESSleft renal cyst decortication.
One notable addition is that of mini-laparoscopic orneedlescopic instruments, which have been and continue tobe used as adjuncts during LESS procedures. For certainprocedures, in addition to the transumbilical single-port, asmall 2- or 3-mm port has been used for a retracting device,requiring no skin suturing and virtually no scar. This adjunctwas embraced as a way to bridge the gap between standardlaparoscopy and LESS in the consensus statement on LESSin 2010.22
Applications
As described earlier, nephrectomy was the initial procedurereported for transumbilical LESS in 2007. Since that timein only 4 years, an impressive array of procedures havebeen successfully completed using a transumbilical LESSapproach, spanning almost the full urological surgical arma-mentarium for intra-abdominal procedures. We summarizethe literature here, including only those procedures com-
Fig. 2 Cosmetic result 6 weeks after LESS renal cystdecortication.
pleted through the umbilicus. We have extracted such datafrom series in which multiple techniques and access siteswere included. As the literature is ever growing, this is notintended to be a comprehensive summary. We hope to givethe reader the current scope of the clinical applicationsutilizing transumbilical LESS. Currently-reported transum-bilical LESS applications by organ systems are detailedbelow.
Kidney
Raman first described nephrectomy using three trocarsthrough a single umbilical incision.2 Kidney surgery com-prises the majority of transumbilical LESS surgery to date.It is therefore instructive to subdivide kidney proceduresinto the following categories: oncology, reconstructive,donor nephrectomy and other. Oncological procedures with
a LESS approach must be able to be completed withoutcompromising cancer outcomes. This began by demonstra-tion of renal mass cryoablation using a 3.8-mm cryoprobe(Endocare, Irvine, CA, USA) through a Uni-X accessdevice.23 The authors described this method with both tran-sumbilical and retroperitoneal approaches. The utility of thismethod was confirmed later in a review of a single-center’stransumbilical LESS experience.24
Extirpative oncological surgery has also been shown to befeasible. Aron et al. reported five partial nephrectomies in200825 using the R-Port access device. An extra 2-mm portwas used for a grasper, and one patient needed an additional5-mm port for liver retraction. The R-Port was again usedwhen carried out on six patients in an overall review ofseveral LESS procedures by Desai.26 Other devices havebeen used for partial nephrectomy including the Uni-X27 andGelPort,28 as well as standard trocars through a single inci-
Table 1 Current devices and instrumentation for LESS (alphabetical order)
Company Design Currentlyavailable
Access devicesAirseal Surgiquest, Orange, CT, USA Maximize movement with small incision
by using oval cannulaYes
GelPOINT AdvancedAccess Platform
Applied Medical, Rancho SantaMargarita, CA, USA
1.5–7-cm incisions with self-retainingports for 5–10-mm diameterinstruments
Accommodates up to 3 instruments(12 mm and two 5 mm in diameter)
Yes
Uni-X Pnavel Systems, Brooklyn, NY, USA Three 5-mm diameter ports/instruments NoX-cone Storz, Tuttlingen, Germany Reusable, accommodates 3 working
channels (5 or 12.5 mm in diameter)Yes
Camera systemsEndocameleon Storz, Tuttlingen, Germany 10-mm diameter with adjustable angle
0° to 120°Yes
Endoeye LTF Olympus, Center Valley, PA, USA Deflectable tip 5–10-mm diameter scope YesExtra long Storz, Tuttlingen, Germany 5-mm diameter with 30° lens YesEyemax Richard Wolf Medical Instruments
Corporation, Vernon Hills, IL, USA5–10-mm diameter with 0–30° digital
lensYes
Ideal Eyes HD Stryker, Kalamazoo, MI, USA 5-mm diameter articulating scope YesInstruments
Roticulator Covidien, Dublin, Ireland 5-mm diameter instruments YesPrebent Various companies Basic curved instruments YesReal Hand Novare, Cupertino, CA, USA 5-mm instruments NoAutonomy laparo-angle Cambridge Endo, Framingham, MA, USA 5-mm articulating instruments Yes
sion29 and homemade access devices.30 Radical nephrec-tomy has also seen broad use in several series.14,24,26,28–31 Acommon practice for right-sided nephrectomy has been theaddition of a small 2–3-mm port to aid with liver retraction.This gives the surgeon a technical advantage while not sac-rificing the cosmetic benefit of LESS. A more recent serieshas shown that non-ischemic partial nephrectomy is safe andfeasible with LESS.32 Table 2 details LESS kidney surgeryfor malignancy.
The full cosmetic benefit of transumbilical LESS can berealized with reconstructive renal procedures. Unlike withmany oncological indications, these do not require extensionof the original incision for specimen extraction. Desai et al.reported the first pyeloplasty using the R-Port with an addi-tional 2-mm port for a grasper and to aid with intracorporealsuturing.33 A similar technique was described for simplenephrectomy in a patient with a poorly functioning leftkidney. The same group later published results with single-session bilateral pyeloplasty in two patients, as well as anileal ureter and a ureteroneocystostomy with a psoas hitch.34
This shows the evolution of transumbilical LESS techniquesto more complex procedures. When compared with conven-tional laparoscopic pyeloplasty, transumbilical LESS pyelo-plasty has been found to have similar immediate outcomes,including length of hospital stay, morphine equivalents, andminor and major complications.15 Surprisingly, they alsofound that median operative times and median estimatedblood loss were lower in patients undergoing LESS. Thismight represent increased attending involvement with LESSinherent at teaching institutions with new techniques.
The transplantation arena has been fertile ground forLESS application and investigation. Transumbilical LESSdonor nephrectomy provides the patient cosmetic benefitand potentially faster recovery time with decreased periop-erative pain compared with conventional laparoscopic andopen donor nephrectomy. The first experience with LESSdonor nephrectomy used the R-Port, as well as a 2-mm portwithout an incision to aid in retraction.35 A comparison withconventional laparoscopy has shown that there is an associ-ated quicker convalescence with LESS patients, includingdays on oral pain medication, days off work and days to100% recovery.36
Other miscellaneous renal procedures have been com-pleted successfully with transumbilical LESS. These includesimple nephrectomy for benign indications and cyst decor-tication. See Table 3 for experience with these procedures,as well as the reconstructive and donor nephrectomyexperience.
Adrenal
A rare application of transumbilical LESS has been foradrenalectomy, perhaps because retraction is so crucial toexpose the gland. Several series have been published to
date,26,30 including the largest that includes a matched case–control study comparing conventional laparoscopic withtransumbilical LESS adrenalectomy.17 Nine LESS proce-dures were compared with 17 conventional laparoscopicadrenalectomies matched to age, sex, surgical indicationsand tumor size. The indications for the LESS procedureswere benign adenoma (n = 3), Cushing’s Syndrome (n = 1)and pheochromocytoma (n = 5). Tumor size differed signifi-cantly between groups, with an average size of 2.8 cm(1–5.4 cm) in the LESS cohort compared with 4.3 cm (2.5–6.0 cm) in the CL group. However, the techniques weresimilar in terms of conversion rate, operative time, estimatedblood loss, complications and hospital stay. The LESS groupdid have a shorter duration of patient controlled anesthesia(0.9 days vs 1.9 days). Table 4 summarizes the current lit-erature in regard to transumbilical LESS adrenalectomy.
Ureter
One of the theoretical advantages of the umbilicus as aportal-of-entry is the ability to operate in all quadrants. Asthe ureter encompasses such a long path, ureteral pathologypresents a potential opportunity to capitalize on the versa-tility of umbilical LESS. The variety of ureteral proceduresspans oncology, reconstructive and stone diseases. Table 5describes current literature for LESS ureteral surgeriesacross this spectrum.
The series of ureterolithotomy described by Lee et al. is thelargest report.42 Here, 30 transumbilical LESS ureterolitho-tomies were carried out successfully with no conversions toconventional laparoscopy. A homemade device was used foraccess using a 2–3-cm umbilical incision. Patient satisfactionwas analyzed and the authors found that 28 out of 30 patients(93.3%) were satisfied with their postoperative outcomes.
Bladder
Current LESS experience with bladder procedures includesthose listed in Table 6. Procedures accomplished to datethrough a LESS approach include radical and partial cystec-tomy, augmentation enterocystoplasty, sacral colpopexy andvesicovaginal fistula repair. Of note, a comparative studycarried out by White et al. looking at sacral colpopexy foundsimilar efficacy and improved cosmesis for transumbilicalLESS versus laparoscopic and robotic techniques.18 Therewere no conversions and no immediate complications. Thepatients showed prolapse reduction at 6 months follow up,and were overall satisfied with the outcomes. The authorsstate that they are exploring this technique robotically toovercome the learning curve associated with the procedure.
Prostate
With tremendous experience in minimally invasive (laparo-scopic and robotic) prostatectomy, it is not surprising that
LESS prostatectomy would ultimately be cautiouslyexplored. This has been described both laparoscopically andwith robotic LESS. Robotic instruments with articulatingtips provide the surgeon with better dexterity when operat-ing through the LESS avenue. The largest series described20 patients undergoing robotic LESS prostatectomy withreasonable mean operative time (187.6 min), estimatedblood loss (128.8 mL) and average length of stay(2.5 days).46 They concluded that robotic assistance“reduces or eliminates instrument crossing, has superiorergonomics, and instrument tip articulation significantlyfacilitates suturing.” Their series is compared with otherLESS prostate series in Table 7.
Robotic LESS
Use of robotics for assistance with LESS procedures wasintended to bring increased dexterity to offset some of thefrustrations with standard laparoscopic LESS surgery. Theda Vinci robotic system (Intuitive Surgical, Sunnyvale, CA,USA) has been used successfully through a single transum-bilical port in a variety of procedures. In 2009, Rane et al.discussed the use of robotics with LESS and its implicationsfor future directions.49 They described how robotics can aidLESS with superior visualization of the operative field,enhanced surgical dexterity and excellent ergonomics.
However, the original da Vinci robotic system was notdesigned specifically for single-site surgery, and thereforehas its own limitations. First, the external size and straightshape of the robotic arms lead to external clashing over asingle port. Second, the original robotic instrument shaftsthemselves do not articulate, and therefore intracorporealclashing can occur as well.
To this end, the newer da Vinci Si surgical system hasbeen modified to be more amenable to single-site surgery.There has been development of VeSPA surgical instruments(Intuitive Surgical) to overcome the aforementioned limita-tions. These instruments are inserted through curved cannu-lae and allow multiple ports through one incision while stillallowing intra-abdominal triangulation. The feasibility ofthis technique was shown in a porcine model in 2010, inwhich the authors completed various kidney procedures(pyeloplasty, partial nephrectomy, nephrectomy) showingimproved ergonomics and minimal instrument clashing.50
Disadvantages
Transumbilical LESS does have difficulties associated withit that the surgeon must weigh with the cosmetic benefit. Asaforementioned, in general utilizing a LESS technique willlead to either no true triangulation or a reliance on curved orbent instruments in order to create triangulation. Thus, thereis a learning curve to LESS that might dissuade communityurologists from accepting LESS into their practice. Another Ta
important aspect of incorporating transumbilical LESS isthe potential cost of newer instruments and access devices. Itmight not be worth both the training and cost associatedwith LESS for the urologist who only has a limited use forLESS. However, there has been no dedicated analysis of costassociated with LESS to this date.
Conclusion
The progression of minimally invasive surgery has ledurologists to explore LESS. Born out of a desire forimproved cosmesis, and the potential for reduced operativetrauma, decreased postoperative pain and complications,transumbilical LESS has successfully been implementedinto the urologist’s armamentarium. However, the futurerole of LESS is still uncertain. Although large specialtycenters have described LESS for virtually all urologicallaparoscopic procedures, it is unclear whether LESS willdiffuse beyond select centers. The majority of data availableare based on non-randomized series, whereby selection biasmight play a significant role. However, a randomized pro-spective trial would be very difficult to complete comparingLESS to conventional laparoscopy. It does seem evident thatthe cosmetic benefit from LESS is real and reproducible, butany incremental benefit apart from cosmesis seems unlikelyto match the leap previously witnessed from open surgery tolaparoscopy.
Surgical device companies have responded by developingaccess devices, scopes and instruments more specificallyaimed towards LESS. As technology improves, this will nodoubt continue to make the transition to LESS easier for moresurgeons. Currently-available LESS training courses shouldbe considered for surgeons interested in LESS techniques tobenefit from the collective experience of early adopters.
The urological transumbilical LESS experience is rapidlygrowing, but many questions remain. Whether the benefits ofLESS truly outweigh its technical challenges is currently un-known. We also cannot predict whether LESS in some formwill become a permanent fixture in our arsenal, or a historicalfootnote. For now, LESS surgery remains the subject ofintense scrutiny, and is a laudable example of surgical cre-ativity aimed at minimizing surgical trauma for our patients.
Conflict of interest
None declared.
References
1 Box G, Averch T, Cadeddu J et al. Nomenclature ofNatural Orifice Transluminal Endoscopic Surgery(NOTES™) and Laparoendoscopic Single-Site Surgery(LESS) procedures in urology. J. Endourol. 2008; 22:2575–81.
2 Raman JD, Bensalah K, Bagrodia A, Stern JM, CadedduJA. Laboratory and clinical development of single keyholeumbilical nephrectomy. Urology 2007; 70: 1039–42.
4 Pelosi MA, Pelosi MA III. Laparoscopic hysterectomy withbilateral salpingo-oophorectomy using a single umbilicalpuncture. N. J. Med. 1991; 8: 721–6.
5 Pelosi MA, Pelosi MA III. Laparoscopic appendectomyusing a single umbilical puncture (minilaparoscopy). J.Reprod. Med. 1992; 37: 588–94.
6 D’Alessio A, Piro E, Tadini B, Beretta F. One-trocartransumbilical laparoscopic-assisted appendectomy inchildren: our experience. Eur. J. Pediatr. Surg. 2002; 12:24–7.
7 Navarra G, Pozza E, Occhionorelli S, Carcoforo P, DoniniI. One-wound laparoscopic cholecystectomy. Br. J. Surg.1997; 84: 695.
8 Piskun G, Rajpal S. Transumbilical laparoscopiccholecystectomy utilizes no incisions outside the umbilicus.J. Laparoendosc. Adv. Surg. Tech. A 1999; 9: 361–4.
9 Kercher KW, Heniford BT, Matthews BD et al.Laparoscopic vs open nephrectomy in 210 consecutivepatients. Surg. Endosc. 2003; 17: 1889–95.
10 Rane A, Kommu S, Eddy B, Bonadio F, Rao P, Rao P.Clinical evaluation of a novel laparoscopic port (R-port)and evolution of the single laparoscopic port procedure(SLiPP). J. Endourol. 2007; 21 (Suppl 1): A22–23.
11 Ponsky LE, Cherullo EE, Sawyer M, Hartke D. Singleaccess site laparoscopic radical nephrectomy: initial clinicalexperience. J. Endourol. 2008; 22: 663–5.
12 Nomura T, Sato F, Takahashi M, Sumino Y, Mimata H.Laparoendoscopic single-site (LESS) retroperitoneal radicalnephrectomy in a patient with renal cell carcinomareceiving hemodialysis. Case Report Med 2011;doi:10.1155/2011/506032.
13 Ponsky LE, Steinway ML, Lengu IJ, Hartke DM, VourgantiS, Cherullo EE. A pfannenstiel single-site nephrectomyand nephroureterectomy: a practical application oflaparoendoscopic single-site surgery. Urology 2009; 74:482–5.
14 Raman JD, Bagrodia A, Cadeddu JA. Single-incision,umbilical laparoscopic versus conventional laparoscopicnephrectomy: a comparison of perioperative outcomes andshort-term measures of convalescence. Eur. Urol. 2009; 55:1198–206.
15 Tracy CR, Raman JD, Bagrodia A, Cadeddu JA.Perioperative outcomes in patients undergoing conventionallaparoscopic versus laparoendoscopic single-sitepyeloplasty. Urology 2009; 74: 1029–35.
16 Raybourn JH III, Rane A, Sundaram CP. Laparoendoscopicsingle-site surgery for nephrectomy as a feasible alternativeto traditional laparoscopy. Urology 2010; 75: 100–3.
17 Jeong BC, Park YH, Han DH, Kim HH. Laparoendoscopicsingle-site and conventional laparoscopic adrenalectomy. J.Endourol. 2009; 23: 1957–60.
18 White WM, Goel RK, Swartz MA, Moore C, Rackley RR,Kaouk JH. Single-port laparoscopic abdominal sacral
colpopexy: initial experience and comparative outcomes.Urology 2009; 74: 1008–12.
19 Park SK, Olweny EO, Best SL, Tracy CR, Mir SA,Cadeddu JA. Patient-reported body image and cosmesisoutcomes following kidney surgery: comparison oflaparoendoscopic single-site, laparoscopic, and opensurgery. Eur. Urol. 2011; 60: 1097–104;doi:10.1016/j.eururo.2011.08.007.
20 Sawyer MD, Ponsky LE. Technical and equipmentchallenges for laparoendoscopic single-site surgery andnatural orifice transluminal endoscopic surgery. BJU Int.2010; 106: 892–6.
21 Castellucci SA, Curcillo PG, Ginsberg PC et al. Single portaccess adrenalectomy. J. Endourol. 2008; 22: 1573–6.
22 Gill IS, Advincula AP, Aron M et al. Consensus statementof the consortium for laparoendoscopic single-site surgery.Surg. Endosc. 2010; 24: 762–8.
23 Goel RK, Kaouk JH. Single port access renal cryoablation(SPARC): a new approach. Eur. Urol. 2008; 53: 1204–9.
24 White WM, Haber GP, Goel RK, Crouzet S, Stein RJ,Kaouk JH. Single-port urological surgery: single-centerexperience with the first 100 cases. Urology 2009; 74:801–4.
25 Aron M, Canes D, Desai MM et al. Transumbilicalsingle-port laparoscopic partial nephrectomy. BJU Int.2008; 103: 516–21.
26 Desai MM, Berger AK, Brandina R et al. Laparoendoscopicsingle-site surgery: initial hundred patients. Urology 2009;74: 805–13.
28 Stein RJ, White WM, Goel RK, Irwin BH, Haber GP,Kaouk JH. Robotic laparoendoscopic single-site surgeryusing GelPort as the access platform. Eur. Urol. 2010; 57:132–7.
29 Rais-Bahrami S, Montag S, Atalla MA, Andonian S,Kavoussi LR, Richstone L. Laparoendoscopic single-sitesurgery of the kidney with no accessory trocars: an initialexperience. J. Endourol. 2009; 23: 1319–24.
30 Jeon HG, Jeong W, Oh CK et al. Initial experience with 50laparoendoscopic single site surgeries using a homemade,single port device at a single center. J. Endourol. 2010;183: 1866–72.
31 Stolzenburg JU, Kallidonis P, Hellawell G et al. Techniqueof laparoscopic-endoscopic single-site surgery radicalnephrectomy. Eur. Urol. 2009; 56: 644–50.
35 Gill IS, Canes D, Aron M et al. Single port transumbilical(E-NOTES) donor nephrectomy. J. Urol. 2008; 180:637–41.
36 Canes D, Berger A, Aron M et al. Laparo-EndoscopicSingle Site (LESS) versus standard laparoscopic left donornephrectomy: matched-pair comparison. Eur. Urol. 2010;57: 95–101.
37 Ganpule AP, Dhawan DR, Kurien A et al.Laparoendoscopic single-site donor nephrectomy: asingle-center experience. Urology 2009; 74: 1238–40.
38 Dubey D, Shrinivas RP, Srikanth G. Transumbilicallaparoendoscopic single-site donor nephrectomy: Withoutthe use of a single port access device. Indian J. Urol. 2011;27: 180–4.
39 Rane A, Ahmed S, Kommu SS, Anderson CJ, RimingtonPD. Single-port “scarless” laparoscopic nephrectomies: theUnited Kingdom experience. BJU Int. 2009; 104: 230–3.
40 Han WK, Park YH, Jeon HG et al. The feasibility oflaparoendoscopic single-site nephrectomy: initialexperience using home-made single-port device. Urology2010; 76: 862–5.
41 Zhang Y, Ye J, Wu G et al. Transumbilicallaparoendoscopic single-site renal pedicle lymphaticdisconnection for refractory chyluria. J. Endourol. 2011;25: 1337–41.
42 Lee JY, Han JH, Kim TH, Yoo TK, Park SY, Lee SW.Laparoendoscopic single-site ureterolithotomy for upperureteral stone disease: the first 30 cases in a multicenterstudy. J. Endourol. 2011; 25: 1293–8.
43 Noguera RJS, Astigueta JC, Carmona O et al. Laparoscopicaugmentation enterocystoplasty through a single trocar.Urology 2009; 73: 1371–4.
44 Kaouk JH, Goel RK, White MA et al. LaparoendoscopicSingle-site Radical Cystectomy and Pelvic Lymph NodeDissection: Initial Experience and 2-Year Follow-up.Urology 2010; 76: 857–61.
45 Abdel-Karim AM, Moussa A, Elsalmy S. Laparoendoscopicsingle-site surgery extravesical repair of vesicovaginalfistula: early experience. Urology 2011; 78: 567–71.
46 White MA, Haber GP, Autorino R et al. Roboticlaparoendoscopic single-site radical prostatectomy:technique and early outcomes. Eur. Urol. 2010; 58: 544–50.
47 Kaouk JH, Goel RK, Haber GP, Crouzet S, Desai MM,Gill IS. Single-port laparoscopic radical prostatectomy.Urology 2008; 72: 1190–3.
48 Barret E, Sanchez-Salas R, Kasraeian A et al. A transitionto laparoendoscopic single-site surgery (LESS) radicalprostatectomy: human cadaver experimental and initialclinical experience. J. Endourol. 2009; 23: 135–40.
49 Rane A, Tan GY, Tewari AK. Laparo-endoscopicsingle-site surgery in urology: is robotics the missing link?BJU Int. 2009; 104: 1041–3.
50 Haber GP, White MA, Autorino R et al. Novel Robotic daVinci instruments for laparoendoscopic single-site surgery.Urology 2010; 76: 1279–82.